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1242 The Journal of Thoracic and CardObjective: We sought to compare the clinical and echocardiographic outcomes of
mitral valve repair for mitral regurgitation in patients with degenerative disease of
the mitral valve with posterior, anterior, or bileaflet prolapse.
Methods: Patients underwent operations from 1981 through 2001: 359 had posterior
(mean age, 60.4 years), 92 had anterior (mean age, 53.3 years), and 250 had bileaflet
(means age, 56.4 years) prolapse. Patients with anterior prolapse were younger
(P .04) and had more associated aortic valve disease (P .02), particularly bicuspid
aortic valve disease (P  .001). Anterior prolapse was corrected by using chordal
replacement with Gore-Tex sutures in most patients, but early on in this series, leaflet
resection, chordal shortening, and chordal transfer were also used. Echocardiograms
were done annually, and clinical follow-up was complete at a mean of 6.9  4.0 years
(range, 0-23 years).
Results: The overall survival at 12 years was 75%  5%, with no difference among
the posterior, anterior, and bileaflet prolapse groups (P  .3). The freedom from
reoperation at 12 years was 96%  2% for posterior, 88%  4% for anterior, and
94%  2% for bileaflet prolapse (P  .019). Anterior prolapse was the only
independent predictor of reoperation. The freedom from moderate or severe mitral
regurgitation at 12 years was 80%  4% for posterior, 65%  8% for anterior, and
67%  6% for bileaflet prolapse (P  .001). Anterior and bileaflet prolapse, age,
ejection fraction of less than 40%, and aortic valve disease were independent
predictors of recurrent moderate or severe mitral regurgitation.
Conclusions: The pathophysiology of mitral regurgitation affects the durability of
mitral valve repair for degenerative disease, and the results of posterior prolapse are
better than those of anterior and bileaflet prolapse. This study indicates that rates of
reoperation underscore the rates of failure of mitral valve repair.
Mitral valve (MV) repair for mitral regurgitation (MR) caused by degen-erative disease of the MV is feasible in more than 90% of patients.1Prolapse of the posterior leaflet (PL) is the most common cause of MR,
valve repair is relatively simple, and the long-term results have been excellent.2,3
Prolapse of the anterior leaflet (AL) and bileaflet (BL) prolapse are more difficult to
repair, and the long-term results are not as good as those for repair of prolapse of
iovascular Surgery ● November 2005
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CDthe PL.2-4 Although there are numerous studies on longitu-
dinal outcomes of MV repair, few, if any, compared the
outcomes on the basis of the prolapsed leaflet or assessed
valve function by means of echocardiography.
This study examines the clinical outcomes and valve func-
tion after MV repair for MR caused by degenerative disease in
patients with isolated PL prolapse, isolated AL prolapse, and
BL prolapse.
Abbreviations and Acronyms
AF  atrial fibrillation
AL  anterior leaflet
BL  bileaflet
MR mitral regurgitation
MVmitral valve
PL  posterior leaflet
TABLE 1. Clinical profile of patients with posterior, anteri
Posterior (%)
No. of patients 359 (51)
Age, y (mean  SD) 60.4 12.0
Range, y 19-88
Male sex 253 (70)
Previous cardiac operation 5 (1)
Healed infective endocarditis 30 (8)
Active infective endocarditis 3 (1)
Marfan syndrome 7 (2)
NYHA class
I 53 (15)
II 120 (33)
III 132 (37)
IV 54 (15)
Associated diseases
Hypertension 107 (30)
Diabetes mellitus 17 (5)
Renal failure 0
PVD disease 6
COPD (FEV1 1) 16 (5)
Preoperative AF 78 (22)
AV disease 18 (5)
Bicuspid aortic valve 4 (1)
Aortic root aneurysm 8 (2)
TV regurgitation 11 (3)
CAD 61 (17)
LVEF
59% 211 (59)
40%-59% 127 (36)
20%-39% 20 (5)
20% 1
Percentages greater than 1 are shown in parentheses. SD, Standard dev
COPD, chronic obstructive pulmonary disease; FEV , forced expiratory volu1
coronary artery disease; LVEF, left ventricular ejection fraction.
The Journal of ThoracicPatients and Methods
From July 1981 through June 2001, 815 patients had operations for
MR caused by leaflet prolapse as a result of degenerative disease
of the MV. The predominant pathology was myxomatous degen-
eration, but cases of “fibroelastic deficiency”5 and dystrophic
calcification of the mitral annulus were included. Patients with
concomitant aortic valve-root and tricuspid valve disease were also
included. The pathology of the MV was recorded prospectively at
the end of each operation. The degree of myxomatous changes was
recorded as mild, moderate, or severe depending on the thickness,
volume, and interchordal hooding of the leaflets. Patients were
divided into 3 groups according to the prolapsing leaflet: PL, AL,
or BL prolapse. Patients with isolated prolapse of a commissure
were classified as having BL prolapse. The operation performed
was MV repair in 701 (86%) patients and MV replacement in 114
(14%) patients. The repair rates increased from 25% in 1982 to
approximately 95% in 1990 and thereafter. The proportions of PL,
AL, and BL prolapse were similar in patients who had repair or
replacement (P  .09). Table 1 shows the clinical profile of the
patients who had MV repair according to the prolapsed leaflet.
nd bileaflet prolapse
Anterior (%) Bileaflet (%) P value
92 (13) 250 (36) .000
53.3 15.6 56.4 13.0 .04
18-82 21-82
65 (71) 194 (78) .13
8 (9) 3 (1) .000
11 (12) 27 (11) .7
1 (1) 1 .8
1 (1) 11 (4) .02
7 (8) 43 (17)
26 (39) 84 (34)
39 (42) 102 (41)
10 (11) 21 (8) .08
29 (31) 44 (18) .001
5 (5) 4 (2) .08
1 3 .20
1 0 .12
4 (4) 11 (4) .75
26 (28) 58 (23) .41
14 (15) 20 (8) .02
8 (9) 1 .000
5 (5) 10 (4) .3
3 (3) 10 (4) .8
16 (14) 23 (9) .016
34 (37) 136 (54)
47 (51) 102 (41)
9 (10) 12 (5)
2 0 .001
; NYHA, New York Heart Association; PVD, peripheral vascular disease;
1 second; AF, atrial fibrillation; AV, aortic valve; TV, tricuspid valve; CAD,or, a
iation
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This series is the experience of one surgeon. The techniques of MV
repair evolved over the years. Prolapse of the PL was corrected by
means of quadrangular, rectangular, or triangular resection with or
without sliding plasty in all patients except in cases of fibroelastic
deficiency, in which the PL was not elongated and had minimal if
any myxomatous changes. In this case the prolapse was corrected
by using chordal replacement with Gore-Tex sutures (W. L. Gore
& Associates, Flagstaff, Ariz). Prolapse of the AL was corrected
by means of triangular resection of the prolapsing segment from
1981 through 1985, chordal shortening from 1981 through 1986,
chordal transfer from 1986 through 1990, and chordal replacement
with Gore-Tex sutures from 1985 to the present. The technique of
chordal replacement with Gore-Tex sutures changed over the
years, and details have been published elsewhere.6,7
Patients with dystrophic calcification of the mitral annulus had
mitral repair if the leaflets were pliable.8
Mitral annuloplasty was performed in all cases, except if the
pathology was fibroelastic deficiency and the mitral annulus was
not dilated. Table 2 lists the operative procedures in each group.
All patients were anticoagulated with warfarin sodium for 3
months and permanently if they had atrial fibrillation (AF).
Follow-up
Intraoperative Doppler echocardiography has been used routinely
since 1985. All patients had an echocardiogram before hospital
discharge and were instructed to have a study every year. Echo-
cardiographic findings were entered prospectively into a database.
TABLE 2. Operative data and follow-up
Posterior (%
MV repair
Segmental resection of posterior leaflet 359 (100)
Segmental resection of anterior leaflet 0
Chordal shortening 0
Chordal transfer 0
Chordal replacement with PTFE sutures 42 (12)
Reconstruction of mitral annulus 9 (3)
Mitral annuloplasty
None 33 (9)
Carpentier ring 50 (14)
Duran ring 72 (20)
Cosgrove or other posterior band 204 (57)
Maze procedure for AF 22 (6)
AV repair or sparing 10 (3)
AV replacement 9 (3)
TV repair 11 (3)
CAB 61 (17)
Crossclamp time, min (mean  SD) 60 23
CPB time, min (mean  SD) 76  27
Duration of follow-up, y (mean  SD)
Clinical 6.9 4.2
Echocardiographic 6.7 4.2
PTFE, Polytetrafluoroethylene; AF, atrial fibrillation; AV, aortic valve; TV, tr
bypass; CPB, cardiopulmonary bypass.Approximately one half of the patients had echocardiographic
1244 The Journal of Thoracic and Cardiovascular Surgery ● Novstudies in our institution, and the MR was recorded as none, trivial,
mild, moderate, or severe (grades 0-4, respectively). If the echo-
cardiographic study was done at an outside institution and the
report read “trace to mild MR,” it was entered into our database as
mild; if it read “mild to moderate MR,” it was entered as moderate;
and if it read “moderate to severe MR,” it was entered as severe.
The follow-up for this study was closed on December 31, 2004. No
patient was lost to clinical follow-up, but 46 had not had an
echocardiogram since discharge from the hospital. Table 1 shows
the follow-up times for both clinical and echocardiographic
evaluations.
Statistical Analysis
SAS 8.2 for Windows was used for all statistical analyses (SAS
Institute Inc, Cary, NC). Continuous variables are reported as the
mean 1 standard deviation; survival estimates are reported as the
mean  1 standard error.
Continuous variables were evaluated with 1-way analysis of
variance, with post-hoc comparisons between subgroups by using
the Scheffe test. Where appropriate, categoric variables were com-
pared with the 2 or Fisher exact tests. Late survival and freedom
from adverse events were estimated by using the nonparametric
Kaplan-Meier method. The log-rank test was used for statistical
comparisons of the Kaplan-Meier curves.
Cox regression analysis with backwards selection was used to
identify the multivariable and independent predictors of late out-
comes. Variables submitted to the models included the following:
age at the time of the operation in increments of 5 years, sex, left
Anterior (%) Bileaflet (%) P value
0 250 (100)
4 (4) 9 (4)
11 (12) 28 (11) NA
13 (14) 35 (14)
68 (74) 186 (74)
0 4 (1)
0 0
19 (21) 31 (12)
35 (38) 59 (24) .001
38 (41) 160 (64)
4 (4) 14 (6) .7
5 (5) 18 (7) .1
14 (15) 4 (2) .001
3 (3) 10 (4) .9
16 (14) 23 (9) .017
70  24 73 26 .001
87  26 90 29 .001
6.6 4.8 6.3 3.7 .2
6.6 5.0 5.9 3.6 .1
d valve; NA, not applicable; SD, standard deviation; CAB, coronary artery)
icuspiventricular ejection fraction of less than 40%, New York Heart
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surgery, surgical priority, coronary artery disease, congestive heart
failure, preoperative AF, preoperative stroke or transient ischemic
attack, concomitant aortic valve surgery, concomitant ascending
aorta repair, concomitant maze procedure, degree of myxomatous
changes, leaflet prolapse, type of repair, and type of mitral annu-
loplasty. Variable retention in the models was set at a P value
of .05.
Results
Operative and Late Mortality
There were 5 operative and 98 late deaths (18 valve-related,
32 cardiac, and 48 noncardiac deaths). Overall survival at
12 years was 75%  3%, that for PL prolapse was 73% 
4%, that for AL prolapse was 73%  6%, and that for BL
prolapse was 78%  8% (P  .3). Table 3 shows the
independent predictors of death.
Thromboembolism
Thromboembolic complications occurred in 65 patients (40
TABLE 3. Cox regression analysis
P value HR 95% CI
Late mortality
Age by increments of 5 y .003 1.3 1.1-1.5
NYHA classes III and IV .002 2.8 1.8-5.4
EF 40% .004 2.4 1.3-4.5
Diabetes .003 3.0 1.4-6.4
COPD .014 2.4 1.2-4.7
Preoperative thromboembolism .003 2.6 1.4-4.8
Valve-related mortality
Age by increments of 5 y .001 2.1 1.5-3.0
Anterior leaflet prolapse .013 4.0 1.3-12
CAD .035 3.0 1.1-8.2
Hypertension .036 2.9 1.1-8.0
Cardiac-related mortality
Age by increments of 5 y .002 1.4 1.1-1.7
Late AF
Age by increments of 5 y .001 1.3 1.2-1.4
Preoperative AF .001 2.3 1.6-3.4
Male sex .017 0.6 0.4-0.9
Thromboembolic complications
Age by increments of 5 y .022 1.1 1.0-1.3
Reoperation on the MV
Anterior leaflet prolapse .047 2.5 1.0-5.0
Recurrent moderate-severe MR
Anterior and bileaflet prolapse .001 2.1 1.3-3.3
Male sex .001 0.5 0.3-0.7
EF 40% .001 4.4 2.4-8.0
AV disease .004 3.2 1.5-7.2
HR, Hazard ratio; CI, confidence interval; NYHA, New York Heart Associ-
ation; EF, ejection fraction; COPD, chronic obstructive pulmonary disease;
CAD, coronary artery disease; AF, atrial fibrillation; MV, mitral valve; MR,
mitral regurgitation; AV, aortic valve.strokes and 25 transient ischemic attacks). The freedom
The Journal of Thoracicfrom thromboembolism at 12 years was 84%  2% for all
patients, 85%  5% for patients with PL prolapse, 86% 
4% for patients with AL prolapse, and 79%  5% for
patients with BL prolapse (P  .4). The only independent
predictor of thromboembolism was age (Table 3).
Anticoagulation-Related Hemorrhage
Eleven patients experienced major hemorrhage during
anticoagulation therapy, and 7 died. The freedom from
major bleeding caused by anticoagulation at 12 years was
94%  2% overall, 93%  3% for patients with PL pro-
lapse, 95% 3% for patients with AL prolapse, and 96%
2% for patients with BL prolapse (P  .9).
Infective Endocarditis
Seven patients had infective endocarditis: 3 required surgi-
cal intervention (2 MV replacements and 1 rerepair), and 4
were treated with antibiotics alone; the infection was cured
in all 7 patients. The freedom from infective endocarditis at
12 years was 99%  0.5% for all patients, 99%  1% for
patients with PL prolapse, 94%  6% for patients with AL
prolapse, and 100% for patients with BL prolapse (P .02).
Reoperations
Twenty-seven patients required MV reoperation: 16 for
recurrent severe MR (caused by recurrent leaflet prolapse),
4 for MR with hemolysis (caused by residual MR), 3 for
mitral stenosis caused by pannus (5-8 years after the opera-
tion), 3 for infective endocarditis, and 1 for a left ventricular–
coronary sinus fistula. In addition, 1 patient needed coronary
artery bypass, and 1 patient had aortic root replacement but
no MV reoperation. Figures 1 and 2 show the freedom from
reoperation in all patients and in the various groups, respec-
tively. Isolated prolapse of the AL was the only independent
Figure 1. Freedom from reoperation in all patients.predictor of MV reoperation (Table 3).
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Twenty-eight patients had severe MR and 61 had moderate
MR during the follow-up. The remaining patients had mild,
trace, or no MR. Figures 3 and 4 show the freedom from
moderate or severe MR in all patients and in the various
groups, respectively. The freedom from severe recurrent
MR at 12 years was 89%  2% for all patients, 92%  3%
for patients with PL prolapse, 86%  6% for patients with
AL prolapse, and 86%  4% for patients with BL prolapse
(P  .13). Predictors of recurrent moderate or severe MR
are shown in Table 3. The degree of myxomatous changes
in the MV, the type of repair used to correct the prolapse,
and the type of mitral annuloplasty had no effect on recur-
rent MR in the entire group or in the AL and BL groups.
Atrial Fibrillation
AF was recorded in 134 patients during the follow-up. Since
the introduction of the maze procedure in our practice, 40
Figure 2. Freedom from reoperation in patients with posterior
(PL), anterior (AL), and bileaflet (BL) prolapse.
Figure 3. Freedom from recurrent moderate or severe mitral re-
gurgitation (MR) in all patients.
1246 The Journal of Thoracic and Cardiovascular Surgery ● Novpatients with preoperative persistent AF had the maze pro-
cedure, and 11 (27%) were in AF at latest follow-up,
whereas 31 patients with persistent AF preoperatively did
not have the maze procedure, and 11 (35%) had AF.
Functional Status
At the latest follow-up, 571 patients were alive and free
from reoperation, and 69% were in New York Heart Asso-
ciation functional class I, 20% were in class II, 10% were in
class III, and 1% were in class IV, without differences
among groups (P  .3).
Discussion
It is generally accepted that the long-term survival after MV
repair is better than after MV replacement.2 We have shown
that survival after MV repair is identical to that of the
general population when the operation is performed in
asymptomatic patients, but it is lower when performed in
patients in functional classes 3 and 4.1 The present study
identified AL prolapse as an independent predictor of valve-
related mortality. It is noteworthy that patients with isolated
AL prolapse were 7 years younger than those with PL
prolapse and yet had the same 12-year survival. However,
patients with AL prolapse had worse left ventricular func-
tion, more aortic valve disease, and the same incidence of
coronary artery disease as patients with PL prolapse. Previous
investigators found that the best clinical outcomes after MV
repair are in patients with isolated prolapse of the PL.2-4
The overall freedom from reoperation was low in our
patients: 94%  1% at 12 years. However, the AL prolapse
group did not fare as well as those with PL prolapse
(88%  4% vs 96%  2% at 12 years, P  .019). Mohty
and associates2 also found a higher rate of reoperation in
Figure 4. Freedom from recurrent moderate or severe mitral re-
gurgitation (MR) in patients with posterior (PL), anterior (AL), and
bileaflet (BL) prolapse.patients with AL prolapse when compared with that seen in
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years, the reoperation rate was 28%  7% for AL prolapse
and 11%  3% for PL prolapse.2
Sequential echocardiographic studies in this series sug-
gested that MV repair did not arrest the progression of the
degenerative changes in the MV. That was probably the
reason patients with AL and BL prolapse had higher recur-
rence rates of moderate and severe MR at follow-up. Pa-
tients with isolated PL prolapse had the best results, and at
12 years, 80% 4% were free from recurrent moderate or
severe MR. Patients with AL or BL prolapse did not do
as well, and the freedom from MR at 12 years was only
65%  8% and 67%  5%, respectively. These findings
suggest that reoperation rates underscore MV repair failure
rates.
Numerous technical improvements have been made in
MV repair, and because this report covers a 20-year expe-
rience, it is possible that the results described here exagger-
ated the problems of recurrent MR associated with AL and
BL prolapse. Indeed, most failures of AL and BL prolapse
occurred in the first decade of our experience, when trian-
gular resection of the AL, chordal shortening, and fewer
Gore-Tex sutures were used to correct the prolapse. Since
we increased the number of synthetic chords during repair
of AL prolapse, we have not had a single case of recurrent
severe MR, although a few patients had moderate MR.
However, because there were only a few cases of severe
MR, the differences between operative techniques did not
reach statistical significance. Mohty and associates2 also
observed this improvement in outcomes in AL prolapse
with increased experience. They found a reduction in the
rates of reoperation at 10 years from 24%  6% to 10% 
2% from the 1980s to 1990s in patients with AL prolapse.
There are several techniques to correct prolapse of the
AL: triangular resection,9 chordal shortening,9 chordal trans-
fer,10,11 chordal replacement with Gore-Tex,6,7 posterior pap-
illary muscle repositioning,12 and edge-to-edge repair.13 Car-
pentier9 was the first to describe triangular resection of the
AL to correct prolapse. Some surgeons still use this tech-
nique routinely for segmental prolapse of the AL.14 We
reserve it for the occasional patient with an excessively
large AL with localized myxomatous aneurysm or infected
leaflet. Chordal shortening has been shown by several sur-
geons to be inferior to chordal transfer15 or chordal replace-
ment.16 However, others believe that chordal shortening is a
good procedure in patients with elongated chordae tendi-
neae.12 There are, however, simpler alternatives to chordal
shortening or chordal transfer, and that appears to be the
practice of most surgeons.12,17,18 The edge-to-edge repair,
commonly known as the “Alfieri stitch,” is probably the
simplest method to repair localized prolapse of the AL. We
do not believe it works in cases of extensive AL or BL
prolapse with advanced myxomatous disease and massive
The Journal of Thoracicdilation of the mitral annulus. Alfieri and colleagues9 re-
cently reported on the results of edge-to-edge technique in a
series of 150 patients with isolated AL prolapse caused by
a variety of pathologies, but degenerative disease was
present in 111 patients. The freedom from reoperation at 9
years was 92%, and only 4 patients had severe recurrent
MR. These results are indeed impressive considering the
complexity of the MV pathology and the simplicity of the
operation. Many surgeons have adopted this technique of
repair, and recently, it was shown to be useful to treat
systolic anterior motion of the AL of the MV after MV
repair for MR.18
During the past 15 years, we have used almost exclu-
sively chordal replacement with 5-0 and 6-0 polytetrafluo-
roethylene sutures (Gore-Tex sutures, W. L. Gore & Asso-
ciates, Inc, Flagstaff, Ariz) to correct prolapse of the AL and
of commissural areas. We find the technique extremely
useful, and it was the single most important factor in making
MV repair feasible in most patients with MR caused by
degenerative disease of the MV in our practice. We also use
Gore-Tex chords to correct prolapse of the PL in patients
with fibroelastic deficiency with small PLs. In patients with
myxomatous disease and voluminous PLs, we believe that
resection with sliding plasty is the appropriate treatment.
In our series of 701 cases of MV repair, isolated PL
prolapse was present in 51% of all patients, isolated AL
prolapse was present in 13%, and BL prolapse was present
in 37%. This relative incidence of PL, AL, and BL prolapse
probably represents the occurrence of the various types of
leaflet prolapse in patients with MR caused by degenerative
disease who are referred for surgical intervention because
approximately 95% of all patients in our practice had MV
repair.1 Thus at least one half of all patients with MR caused
by degenerative disease can have a relatively simple and
lasting repair. The results of repair in patients with AL and
BL prolapse are also satisfactory and probably better than
described in this study because of newer methods of repair.
Finally, patients with isolated prolapse of the AL in this
series were different from the other 2 subgroups in several
aspects: they were younger; had more aortic valve disease,
particularly bicuspid aortic valve; had worse left ventricular
ejection fraction; and had more coronary artery disease than
patients with isolated PL prolapse.
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Discussion
Dr Friedrich-Wilhelm Mohr (Leipzig, Germany). First, I would
like to congratulate our President for these excellent results and
this study with follow-up up to 100%. This article analyzes the
clinical and echocardiographic outcomes of 701 patients undergo-
ing MV repair during a time period of 20 years performed by a
single surgeon. Different repair techniques have been applied
during this time period, especially to correct for anterior leaflet
prolapse, such as chordal shortening and replacement and transfer
for the anterior leaflet, and most often for the posterior leaflet,
resection techniques as described by Carpentier.
As in many other series, isolated posterior leaflet prolapse was
most frequent in 51% of all patients, isolated prolapse of the
anterior leaflet in 13% only, and bileaflet prolapse in 37%. The
excellent results being reported support the high success rate of
95% repair, even in complex cases.
Looking into long-term durability and success rate, overall
survival was 75%, with no difference among the groups. Looking
into both recurrence of MR and freedom of reoperation, isolated
posterior leaflet prolapse repair significantly was superior to ante-
1248 The Journal of Thoracic and Cardiovascular Surgery ● Novrior and bileaflet repair techniques, which confirms earlier reports
by Carpentier and many others.
The most interesting aspect of this study seems to me that a
single surgeon’s experience during a 20-year time period is re-
viewed, and several repair techniques, especially for anterior leaf-
let prolapse, were applied. This leads to my first question. Was
there any significant difference when applying chordal replace-
ment instead of shortening and transfer techniques for anterior
leaflet repair? It has not been addressed in your slides.
Question two. The article did not address the use of specific
annuloplasty rings, such as complete rings or semicircular bands.
Can you comment on your selection criteria for annuloplasty rings
and whether this might have had an effect on patients with either
anterior leaflet or bileaflet prolapses because these patients often
present with a more pronounced ring dilatation at the time of the
operation?
Question three. The improved imaging technology, like intra-
operative transesophageal echocardiography, allows for better pre-
operative assessment and intraoperative quality control. Did this
technology specifically influence your intraoperative decision
making and postoperative outcome?
Dr David. Thank you, Dr Mohr. You asked some important
questions. There was no difference in outcomes among patients
who had leaflet resection, chordal shortening, chordal transfer, or
chordal replacement with Gore-Tex sutures. I have to admit,
however, that early in my experience, we had very few leaflet
resections, and these were in highly selected patients, all of whom
did well. From 1983 through 1986, I used chordal transfer and
chordal shortening, and soon after the introduction of Gore-Tex
sutures to replace chordae tendineae in 1985, we just about aban-
doned the other techniques. In other words, the sample size of a
leaflet resection, chordal shortening, and chordal transfer were too
small in comparison with chordal replacement, and this might
explain the similar failure rates.
The type of annuloplasty ring had no effect on the outcomes
either. Actually, a few patients had no annuloplasty ring, and their
outcomes were also similar, and that is perhaps because of Pro-
fessor Carpentier’s influence on our views of degenerative disease
of the MV. Thus in patients with myxomatous degeneration of the
MV, the entire apparatus is involved by the degenerative process.
The annulus is almost invariably dilated, and an annuloplasty is an
important part of the repair, but in patients with what Professor
Carpentier refers to as “fibroelastic deficiency,” the annulus is
usually normal, the leaflets are relatively small, and in some of
these patients, I repair the prolapse and do not perform an annu-
loplasty. Patients with fibroelastic deficiency are often older and
have more localized disease caused by ruptured chordae, usually
P2. Approximately 100 patients had a Carpentier ring, 166 had a
Duran ring, and 402 had a posterior band of Dacron, mostly the
Cosgrove band. There was no difference in outcomes whether it
was a band, a ring, or no ring.
Finally, I have been fortunate to have had transesophageal
echocardiography in the operating room well before most of you
because one of the cardiologists I worked with in the 1980s was an
investigator for a transesophageal probe, but even before that, he
used to come to the operating room and get transepicardial echo-
cardiograms to assess MV function after repair. Echocardiography
has been the single most important diagnostic tool to select pa-
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CDtients for mv repair, particularly if they are asymptomatic, and also
in assisting us in assessing valve function in the operating room.
We have learned not to accept more than mild MR and no residual
prolapse at all after repair. I believe that the anatomy of the MV is
very important in predicting long-term outcomes after repair. Mild
MR without any prolapse remains mild, but the same is not true if
a prolapsing segment is left unattended.
Dr Alain Carpentier (Paris, France). Of course I enjoyed
very much this presentation, and I have a lot of questions, but I am
going to restrict it. Number one, an important question. You
pointed out that it is very difficult to describe and to analyze the
results according to the physiopathology, and you are right, but we
found that it is also important to analyze the results according to
the disease itself. And as you know, there are several types of
degenerative valvular diseases, particularly, excluding Marfan, the
so-called Barlow with excess tissue and fibroelastic deficiency
with no excess tissue. Usually when you have excess tissue you
have a higher risk of recurrence according to Laplace’s law. This
is because the larger the tissue, the larger the stress and the higher
the risk of recurrence. Therefore my first question is whether you
were able to analyze the cause or to separate the groups and
whether you found a differences depending on whether it is a
fibroelastic deficiency or Barlow?
Dr David. That is an important question. Ninety-two patients
had what you classify as fibroelastic deficiency. Of the 92, most of
them, I do not recall the precise number, had prolapse of the
posterior leaflet. There were some patients in this group who had
bileaflet prolapse caused by ruptured chordae tendineae. In our
series, however, most patients had myxomatous degeneration of
the MV and dilation of the mitral annulus. I believe patients with
fibroelastic deficiency do better in the long term than those with
generalized myxomatous degeneration of the entire MV, but we
could not prove this in our study. I think it is noteworthy that
patients with fibroelastic deficiency were much older than those
with advanced myxomatous changes. Thus although recurrent MR
might be less common, the overall survival might be shorter
because of their age.
Dr Carpentier. Were able to analyze the results depending on
the cause of prolapse being chordal rupture plus elongation or only
elongation?
The Journal of ThoracicDr David. It made no difference, to be quite honest.
Dr Carpentier. You did not analyze that?
Dr David. It made no difference if the prolapse was due to
chordal elongation or rupture.
Dr Carpentier. What about annulus calcification, associated
annulus calcification?
Dr David. Only 13 patients in this series had reconstruction of
the mitral annulus.
Dr Carpentier. You did decalcify the annulus?
Dr David. We removed the entire calcium bar. Unlike you, we
cover the area with fresh autologous pericardium, reattach the
posterior leaflet, and then put the ring in. In those patients, believe
it or not, there was just one failure over our 20-year experience.
This is a good repair as well. But they were selected patients, and
I did not repair all of them.
Dr Carpentier. I believe it. It is just more complicated to do it
this way than to just resect the valve and to reconstruct the annulus,
but next time you are going to do it.
You did not mention systolic anterior motion of the anterior
leaflet of the mitral valve (SAM).
Dr David. It has been just about abolished in our practice since
we learned what causes SAM in the operating room. Particularly in
patients who have a hyperdynamic ventricle before the operation
and a large posterior leaflet, we really shorten the height of the
posterior leaflet, and by doing this, we just about abolished SAM.
Only 2 patients in the past 10 years required a second pump run for
SAM. It is something of the past, I believe.
Dr Carpentier. Therefore in other words you pay attention
to prevent SAM, and—this is for the audience—you take the
precaution of reducing the height to, what, 15 mm, as we
suggested?
Dr David. My cutoff is a centimeter. I make the height of the
posterior leaflet 1 cm or less, depending on the height of the
anterior leaflet. If the posterior is 1.5 cm but the anterior is 4 cm,
it probably is going to be all right. I believe the height of the
posterior leaflet should be less than one third of the height of the
anterior leaflet. By using this rule, we can prevent SAM in almost
all patients. Mind you, if the heart is very hyperdynamic, I still
worry about SAM, and I tend to detach the entire posterior leaflet
and shorten it.
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